Chao Xie
Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Cyclooxygenase 2 | 6 | 2005 | 77 |
Why?
| Fracture Healing | 4 | 2005 | 23 |
Why?
| Bone and Bones | 6 | 2004 | 99 |
Why?
| Bone Transplantation | 5 | 2005 | 29 |
Why?
| Osteogenesis | 6 | 2004 | 33 |
Why?
| Bone Regeneration | 3 | 2004 | 18 |
Why?
| Mesenchymal Stem Cells | 4 | 2004 | 24 |
Why?
| Tissue Engineering | 3 | 2004 | 25 |
Why?
| Receptors, Prostaglandin E | 3 | 2009 | 17 |
Why?
| Tamoxifen | 3 | 2007 | 38 |
Why?
| Mesenchymal Stem Cell Transplantation | 3 | 2004 | 9 |
Why?
| Chondrogenesis | 2 | 2009 | 17 |
Why?
| Stem Cells | 3 | 2005 | 107 |
Why?
| Receptors, Estrogen | 2 | 2003 | 44 |
Why?
| Genetic Engineering | 1 | 2007 | 16 |
Why?
| Mice | 18 | 2003 | 623 |
Why?
| Osteolysis | 3 | 2008 | 18 |
Why?
| Animals | 20 | 2003 | 1031 |
Why?
| Transplantation, Homologous | 4 | 2005 | 94 |
Why?
| Integrases | 3 | 2007 | 36 |
Why?
| Rheumatoid Factor | 2 | 1995 | 9 |
Why?
| Periosteum | 2 | 2005 | 12 |
Why?
| Superantigens | 2 | 1995 | 5 |
Why?
| Mice, Knockout | 3 | 2006 | 265 |
Why?
| Neovascularization, Physiologic | 4 | 2005 | 68 |
Why?
| Receptors, Prostaglandin E, EP4 Subtype | 3 | 2009 | 14 |
Why?
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 1995 | 11 |
Why?
| Enterotoxins | 1 | 1995 | 15 |
Why?
| Chondrocytes | 2 | 2007 | 26 |
Why?
| Genes, Immunoglobulin | 1 | 1995 | 28 |
Why?
| B-Lymphocyte Subsets | 1 | 1995 | 33 |
Why?
| Biocompatible Materials | 1 | 2004 | 32 |
Why?
| Bony Callus | 2 | 2009 | 13 |
Why?
| Lymphocyte Activation | 1 | 1995 | 137 |
Why?
| Mice, Inbred C57BL | 6 | 2003 | 318 |
Why?
| Disease Models, Animal | 4 | 2004 | 349 |
Why?
| RANK Ligand | 2 | 2009 | 30 |
Why?
| Signal Transduction | 3 | 2009 | 313 |
Why?
| Mice, Mutant Strains | 2 | 2004 | 77 |
Why?
| Bone Matrix | 1 | 2011 | 13 |
Why?
| Proto-Oncogene Proteins c-met | 1 | 2011 | 17 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2011 | 35 |
Why?
| Piperidines | 1 | 2011 | 34 |
Why?
| Osteosarcoma | 1 | 2011 | 31 |
Why?
| Base Sequence | 5 | 1992 | 371 |
Why?
| Pyridines | 1 | 2011 | 61 |
Why?
| Feasibility Studies | 2 | 2008 | 144 |
Why?
| Tomography, X-Ray Computed | 3 | 2004 | 321 |
Why?
| Jaw Diseases | 1 | 2010 | 7 |
Why?
| Osteonecrosis | 1 | 2010 | 11 |
Why?
| Osteomyelitis | 1 | 2010 | 39 |
Why?
| Receptors, Androgen | 2 | 2003 | 29 |
Why?
| Mice, Inbred C3H | 2 | 2005 | 86 |
Why?
| Bone Density Conservation Agents | 1 | 2010 | 25 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2009 | 42 |
Why?
| Femur | 2 | 2006 | 37 |
Why?
| Cartilage | 2 | 2005 | 33 |
Why?
| Coated Materials, Biocompatible | 1 | 2008 | 15 |
Why?
| Calcification, Physiologic | 1 | 2008 | 23 |
Why?
| Urokinase-Type Plasminogen Activator | 1 | 2008 | 38 |
Why?
| Germ-Line Mutation | 1 | 2008 | 22 |
Why?
| Dependovirus | 1 | 2008 | 29 |
Why?
| Dinoprostone | 1 | 2009 | 55 |
Why?
| Gene Targeting | 1 | 2008 | 51 |
Why?
| Up-Regulation | 1 | 2009 | 183 |
Why?
| Osteoarthritis | 1 | 2009 | 51 |
Why?
| beta Catenin | 1 | 2009 | 34 |
Why?
| Immunohistochemistry | 2 | 2004 | 355 |
Why?
| DNA Primers | 1 | 2008 | 208 |
Why?
| Bone Neoplasms | 1 | 2008 | 83 |
Why?
| Peptide Fragments | 1 | 2008 | 144 |
Why?
| Fibroblasts | 1 | 2009 | 179 |
Why?
| Polymerase Chain Reaction | 1 | 2008 | 279 |
Why?
| Gene Expression Profiling | 1 | 2008 | 138 |
Why?
| Cattle | 1 | 2007 | 176 |
Why?
| Bone Density | 1 | 2006 | 62 |
Why?
| Immunoglobulin M | 2 | 1995 | 81 |
Why?
| Bone Development | 1 | 2005 | 30 |
Why?
| Phenotype | 5 | 1992 | 303 |
Why?
| Ovarian Follicle | 1 | 2004 | 13 |
Why?
| Infertility, Female | 1 | 2004 | 17 |
Why?
| Mammary Glands, Animal | 1 | 2003 | 14 |
Why?
| HLA-DR Antigens | 2 | 1992 | 37 |
Why?
| Arthritis, Rheumatoid | 2 | 1992 | 53 |
Why?
| Aging | 1 | 2009 | 275 |
Why?
| Drug Evaluation, Preclinical | 2 | 2004 | 65 |
Why?
| Prostatic Neoplasms | 1 | 2008 | 120 |
Why?
| Cell Line | 1 | 2007 | 375 |
Why?
| Myocardium | 1 | 2004 | 119 |
Why?
| Cell Line, Tumor | 3 | 2003 | 208 |
Why?
| Mice, Transgenic | 3 | 2005 | 209 |
Why?
| Cells, Cultured | 3 | 1995 | 447 |
Why?
| Myocardial Infarction | 1 | 2004 | 129 |
Why?
| Immunoglobulin Variable Region | 2 | 1995 | 22 |
Why?
| Immunoglobulin Heavy Chains | 2 | 1995 | 24 |
Why?
| Humans | 11 | 1992 | 1856 |
Why?
| Clone Cells | 3 | 1993 | 92 |
Why?
| T-Lymphocytes, Helper-Inducer | 2 | 1995 | 38 |
Why?
| Molecular Sequence Data | 4 | 1992 | 404 |
Why?
| Bone Remodeling | 2 | 2005 | 33 |
Why?
| Osteoclasts | 2 | 2009 | 48 |
Why?
| Cell Differentiation | 3 | 2004 | 262 |
Why?
| Lymphocyte Cooperation | 1 | 1995 | 12 |
Why?
| Bone Morphogenetic Protein 2 | 2 | 2005 | 21 |
Why?
| Cell Proliferation | 2 | 2005 | 227 |
Why?
| Immune Tolerance | 1 | 1995 | 72 |
Why?
| Growth Substances | 1 | 2004 | 51 |
Why?
| Female | 7 | 1992 | 1643 |
Why?
| Sequence Alignment | 1 | 1995 | 114 |
Why?
| Graft Survival | 1 | 2004 | 74 |
Why?
| Bone Morphogenetic Proteins | 2 | 2005 | 42 |
Why?
| Sequence Homology, Amino Acid | 1 | 1995 | 156 |
Why?
| T-Lymphocyte Subsets | 1 | 1995 | 70 |
Why?
| Imaging, Three-Dimensional | 1 | 2004 | 58 |
Why?
| Amino Acid Sequence | 2 | 1993 | 319 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 243 |
Why?
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1993 | 18 |
Why?
| Protein Structure, Secondary | 1 | 1993 | 54 |
Why?
| Male | 6 | 1992 | 1553 |
Why?
| Transforming Growth Factor beta | 2 | 2005 | 99 |
Why?
| Gene Expression Regulation | 2 | 2007 | 277 |
Why?
| Apoptosis | 2 | 2004 | 265 |
Why?
| Biological Availability | 1 | 2011 | 36 |
Why?
| B-Lymphocytes | 1 | 1995 | 134 |
Why?
| Mice, Nude | 1 | 2011 | 72 |
Why?
| Histocompatibility Antigens Class II | 1 | 1992 | 50 |
Why?
| Neoplasm Invasiveness | 1 | 2011 | 105 |
Why?
| Administration, Oral | 1 | 2011 | 170 |
Why?
| Polyethylene | 1 | 2009 | 11 |
Why?
| Receptors, Prostaglandin E, EP2 Subtype | 1 | 2009 | 13 |
Why?
| Receptors, Prostaglandin E, EP1 Subtype | 1 | 2009 | 9 |
Why?
| S100 Proteins | 1 | 2009 | 19 |
Why?
| Immunity | 1 | 2010 | 46 |
Why?
| Cell Cycle | 1 | 2011 | 121 |
Why?
| T-Lymphocytes | 1 | 1993 | 182 |
Why?
| Staphylococcal Infections | 1 | 2010 | 63 |
Why?
| Particulate Matter | 1 | 2009 | 22 |
Why?
| Calcium-Binding Proteins | 1 | 2009 | 49 |
Why?
| Receptors, Urokinase Plasminogen Activator | 1 | 2008 | 8 |
Why?
| Materials Testing | 1 | 2008 | 28 |
Why?
| Fractures, Bone | 1 | 2009 | 66 |
Why?
| Protein Transport | 1 | 2009 | 101 |
Why?
| Surface Properties | 1 | 2008 | 63 |
Why?
| Phosphorylation | 1 | 2011 | 224 |
Why?
| Mice, SCID | 1 | 2008 | 61 |
Why?
| Adenoviridae | 1 | 2008 | 60 |
Why?
| Biofilms | 1 | 2010 | 23 |
Why?
| Chronic Disease | 1 | 2010 | 267 |
Why?
| Cartilage, Articular | 1 | 2009 | 49 |
Why?
| Cell Communication | 1 | 2008 | 72 |
Why?
| Neovascularization, Pathologic | 1 | 2008 | 64 |
Why?
| Incidence | 1 | 2010 | 336 |
Why?
| Collagen Type II | 1 | 2007 | 14 |
Why?
| Crosses, Genetic | 1 | 2007 | 47 |
Why?
| Recombinant Fusion Proteins | 1 | 2009 | 189 |
Why?
| Osteocalcin | 1 | 2005 | 19 |
Why?
| Cytokines | 1 | 2010 | 207 |
Why?
| Biomechanics | 1 | 2006 | 79 |
Why?
| Embryo, Mammalian | 1 | 2007 | 99 |
Why?
| Acid Phosphatase | 1 | 2005 | 31 |
Why?
| Inflammation | 1 | 2009 | 208 |
Why?
| Alkaline Phosphatase | 1 | 2005 | 59 |
Why?
| Stromal Cells | 1 | 2005 | 41 |
Why?
| Superovulation | 1 | 2004 | 4 |
Why?
| In Situ Nick-End Labeling | 1 | 2004 | 65 |
Why?
| GABA Plasma Membrane Transport Proteins | 1 | 2004 | 1 |
Why?
| Troponin | 1 | 2004 | 6 |
Why?
| Receptor, IGF Type 1 | 1 | 2003 | 11 |
Why?
| Uterus | 1 | 2004 | 49 |
Why?
| Sex Factors | 1 | 2006 | 284 |
Why?
| DNA | 2 | 1992 | 262 |
Why?
| Connexin 43 | 1 | 2004 | 14 |
Why?
| Rats, Wistar | 1 | 2004 | 75 |
Why?
| Morphogenesis | 1 | 2003 | 47 |
Why?
| Promoter Regions, Genetic | 1 | 2007 | 188 |
Why?
| Random Allocation | 1 | 2004 | 160 |
Why?
| Membrane Transport Proteins | 1 | 2004 | 43 |
Why?
| Models, Biological | 1 | 2009 | 410 |
Why?
| Bone Marrow Transplantation | 1 | 2005 | 90 |
Why?
| Gene Therapy | 1 | 2005 | 89 |
Why?
| Insulin-Like Growth Factor I | 1 | 2003 | 64 |
Why?
| Isoenzymes | 1 | 2005 | 144 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 2003 | 68 |
Why?
| Transfection | 1 | 2005 | 237 |
Why?
| Cell Movement | 1 | 2004 | 163 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2004 | 119 |
Why?
| Binding Sites | 1 | 2003 | 213 |
Why?
| Cell Division | 1 | 2003 | 273 |
Why?
| Adult | 1 | 1995 | 1317 |
Why?
| Transcription, Genetic | 1 | 2003 | 253 |
Why?
| Sjogren's Syndrome | 1 | 1995 | 13 |
Why?
| Antigens, CD3 | 1 | 1995 | 37 |
Why?
| Cross Reactions | 1 | 1995 | 63 |
Why?
| Antibody Specificity | 1 | 1995 | 71 |
Why?
| Rats | 1 | 2004 | 530 |
Why?
| HLA-DRB1 Chains | 1 | 1992 | 3 |
Why?
| Rheumatoid Nodule | 1 | 1992 | 4 |
Why?
| Homozygote | 1 | 1992 | 68 |
Why?
| Alleles | 1 | 1992 | 108 |
Why?
| Genotype | 1 | 1992 | 175 |
Why?
| Middle Aged | 1 | 1992 | 1161 |
Why?
|
|
Xie's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
